Compare TMUS & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMUS | AZN |
|---|---|---|
| Founded | 1994 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.2B | 285.7B |
| IPO Year | 2004 | N/A |
| Metric | TMUS | AZN |
|---|---|---|
| Price | $211.15 | $188.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $258.31 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 1.6M |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.93% | 1.75% |
| EPS Growth | ★ 0.62 | N/A |
| EPS | ★ 9.72 | N/A |
| Revenue | ★ $40,604,000,000.00 | N/A |
| Revenue This Year | $9.28 | $10.13 |
| Revenue Next Year | $4.60 | $6.21 |
| P/E Ratio | ★ $21.75 | $31.91 |
| Revenue Growth | ★ 9.03 | N/A |
| 52 Week Low | $181.36 | $61.24 |
| 52 Week High | $272.60 | $212.71 |
| Indicator | TMUS | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 52.92 |
| Support Level | $202.56 | $89.28 |
| Resistance Level | $211.81 | $211.32 |
| Average True Range (ATR) | 4.46 | 3.41 |
| MACD | -0.84 | -2.57 |
| Stochastic Oscillator | 49.07 | 40.13 |
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 86 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 8 million residential and business customers with its wireless network. It also serves 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.